SinoMed_admin

NOVA Trial Selected for LINNC 2026 Trials Book Alongside Landmark BASIS Study

SinoMed_admin2026-10-20T17:54:53+08:00

2026-6-5

NOVA Trial Selected for LINNC 2026 Trials Book Alongside Landmark BASIS StudySinoMed_admin2026-10-20T17:54:53+08:00

HT Supreme™ CE IFU Expanded: One-Month DAPT Guidance Now Included for All-Comer Patients

SinoMed_admin2026-10-20T17:52:41+08:00

2026-5-21

HT Supreme™ CE IFU Expanded: One-Month DAPT Guidance Now Included for All-Comer PatientsSinoMed_admin2026-10-20T17:52:41+08:00

GHUNTER® Intracranial Thrombectomy Stent Receives EU CE MDR Certification

SinoMed_admin2026-10-20T17:48:57+08:00

2026-2-25

GHUNTER® Intracranial Thrombectomy Stent Receives EU CE MDR CertificationSinoMed_admin2026-10-20T17:48:57+08:00

PIONEER IV Clinical Trial Interim Results Published in European Heart Journal

SinoMed_admin2026-10-20T17:39:48+08:00

2026-2-15

PIONEER IV Clinical Trial Interim Results Published in European Heart JournalSinoMed_admin2026-10-20T17:39:48+08:00

COMETIU™ Intracranial Drug-Coated Stent System Receives FDA Breakthrough Device Designation

SinoMed_admin2026-10-20T17:37:28+08:00

2025-8-7

COMETIU™ Intracranial Drug-Coated Stent System Receives FDA Breakthrough Device DesignationSinoMed_admin2026-10-20T17:37:28+08:00

HT Supreme™ Drug-Eluting Stent System Receives U.S. FDA Conditional Premarket Approval

SinoMed_admin2026-10-20T17:33:21+08:00

2025-7-22

HT Supreme™ Drug-Eluting Stent System Receives U.S. FDA Conditional Premarket ApprovalSinoMed_admin2026-10-20T17:33:21+08:00

PIONEER-III Global IDE Trial Reports Five-Year Results for HT Supreme™ at TCT 2024

SinoMed_admin2026-10-20T17:28:07+08:00

2024-10-28

PIONEER-III Global IDE Trial Reports Five-Year Results for HT Supreme™ at TCT 2024SinoMed_admin2026-10-20T17:28:07+08:00

HT Supreme™ Drug-Eluting Stent System Receives EU MDR Certification

SinoMed_admin2026-10-20T17:26:21+08:00

2023-11-1

HT Supreme™ Drug-Eluting Stent System Receives EU MDR CertificationSinoMed_admin2026-10-20T17:26:21+08:00

SINOMED Strengthens Neurointerventional Platform with Strategic Acquisition of 72.73% Stake in U.S. eLum Technologies

SinoMed_admin2026-10-20T17:23:33+08:00

2023-9-7

SINOMED Strengthens Neurointerventional Platform with Strategic Acquisition of 72.73% Stake in U.S. eLum TechnologiesSinoMed_admin2026-10-20T17:23:33+08:00

SC HONKYTONK™ Semi-Compliant Coronary Balloon Dilatation Catheter Receives FDA 510(k) Clearance

SinoMed_admin2026-10-20T17:17:41+08:00

2023-2-1

SC HONKYTONK™ Semi-Compliant Coronary Balloon Dilatation Catheter Receives FDA 510(k) ClearanceSinoMed_admin2026-10-20T17:17:41+08:00